Thermo Fisher Scientific Aktie 977576 / US8835561023
565.22
USD
-4.35
USD
-0.76 %
21:59:58
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Thermo Fisher Scientific Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Thermo Fisher Scientific Inc | 0.30 | 1.72 | USD |
| 2024 | Thermo Fisher Scientific Inc | 0.30 | 1.56 | USD |
| 2023 | Thermo Fisher Scientific Inc | 0.26 | 1.40 | USD |
| 2022 | Thermo Fisher Scientific Inc | 0.22 | 1.20 | USD |
| 2021 | Thermo Fisher Scientific Inc | 0.16 | 1.04 | USD |
| 2020 | Thermo Fisher Scientific Inc | 0.19 | 0.88 | USD |
| 2019 | Thermo Fisher Scientific Inc | 0.23 | 0.76 | USD |
| 2018 | Thermo Fisher Scientific Inc | 0.30 | 0.68 | USD |
| 2017 | Thermo Fisher Scientific Inc | 0.32 | 0.60 | USD |
| 2016 | Thermo Fisher Scientific Inc | 0.43 | 0.60 | USD |
Gewinn je Aktie- Thermo Fisher Scientific
| 17.7 25 | 16.5 24 | 15.4 23 | 17.6 22 | 19.5 21 | 16.0 20 | 9.2 19 |
Umsatz je Aktie- Thermo Fisher Scientific
| 118 25 | 112 24 | 110 23 | 114 22 | 98.8 21 | 80.7 20 | 63.4 19 |
KGV- Thermo Fisher Scientific
| 32.7 25 | 31.5 24 | 34.4 23 | 31.2 22 | 34.3 21 | 29.2 20 | 35.4 19 |
Thermo Fisher Scientific Inc: Die Aktie (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | 17.74 | 16.53 | 15.45 | 17.63 | 19.46 | 15.96 | 9.17 |
| Gewinn je Aktie (unverwässert) | 17.78 | 16.58 | 15.53 | 17.73 | 19.61 | 16.10 | 9.24 |
| Gewinn je Aktie (verwässert) | 17.74 | 16.54 | 15.45 | 17.64 | 19.46 | 15.98 | 9.17 |
| Dividende je Aktie | 1.72 | 1.56 | 1.40 | 1.20 | 1.04 | 0.88 | 0.76 |
| Veränderung Dividende je Aktie in % | 10.26 | 11.43 | 16.67 | 15.38 | 18.18 | 15.79 | 11.76 |
| Gesamtdividendenausschüttung in Mio. | 636.00 | 583.00 | 523.00 | 455.00 | 395.00 | 337.00 | 297.00 |
Thermo Fisher Scientific Inc: Unternehmenskennzahlen (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 117.87 | 111.96 | 110.46 | 114.00 | 98.77 | 80.75 | 63.38 |
| KGV (Jahresendkurs, Gewinn unverwässert) | 32.66 | 31.45 | 34.35 | 31.22 | 34.29 | 29.15 | 35.42 |
| KGV (Jahresendkurs, Gewinn verwässert) | 32.66 | 31.45 | 34.35 | 31.22 | 34.29 | 29.15 | 35.42 |
| Dividendenrendite Jahresende in % | 0.30 | 0.30 | 0.26 | 0.22 | 0.16 | 0.19 | 0.23 |
| Eigenkapitalquote in % | 48.52 | 51.04 | 47.45 | 45.44 | 43.08 | 49.97 | 50.83 |
| Fremdkapitalquote in % | 51.48 | 48.96 | 52.55 | 54.56 | 56.92 | 50.03 | 49.17 |
Thermo Fisher Scientific Inc: GuV (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 44’556.00 | 42’879.00 | 42’857.00 | 44’915.00 | 39’211.00 | 32’218.00 | 25’542.00 |
| Umsatzveränderung in % | 3.91 | 0.05 | -4.58 | 14.55 | 21.71 | 26.14 | 4.86 |
| Bruttoergebnis vom Umsatz | 16’778.00 | 17’728.00 | 17’194.00 | 19’011.00 | 19’634.00 | 16’027.00 | 11’344.00 |
| Bruttoergebnisveränderung in % | -5.36 | 3.11 | -9.56 | -3.17 | 22.51 | 41.28 | 3.24 |
| Operatives Ergebnis | 8’109.00 | 7’662.00 | 7’446.00 | 8’525.00 | 10’318.00 | 7’926.00 | 4’259.00 |
| Veränderung Operatives Ergebnis in % | 5.83 | 2.90 | -12.66 | -17.38 | 30.18 | 86.10 | 9.99 |
| Ergebnis vor Steuern | 7’308.00 | 7’037.00 | 6’298.00 | 7’835.00 | 8’841.00 | 7’225.00 | 4’070.00 |
| Veränderung Ergebnis vor Steuern in % | 3.85 | 11.73 | -19.62 | -11.38 | 22.37 | 77.52 | 24.77 |
| Ergebnis nach Steuer | 6’737.00 | 6’335.00 | 5’995.00 | 6’950.00 | 7’725.00 | 6’375.00 | 3’696.00 |
| Veränderung Ergebnis nach Steuer in % | 6.35 | 5.67 | -13.74 | -10.03 | 21.18 | 72.48 | 25.80 |
Thermo Fisher Scientific Inc: Bilanz (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 56’807 | 47’650 | 51’884 | 53’006 | 54’146 | 34’545 | 28’706 |
| Langzeit Gesamtverbindlichk. je Aktie | - | 90.13 | 97.95 | 92.18 | 103.21 | 61.11 | 56.45 |
| Eigenkapital | 53’537 | 49’671 | 46’842 | 44’148 | 40’977 | 34’507 | 29’675 |
| Veränderung Eigenkapital in % | 7.73 | 6.10 | 6.27 | 7.81 | 18.22 | 16.28 | 7.57 |
| Bilanzsumme | 110’343 | 97’321 | 98’726 | 97’154 | 95’123 | 69’052 | 58’381 |
| Veränderung Bilanzsumme in % | 13.38 | -1.42 | 1.62 | 2.14 | 37.76 | 18.28 | 3.82 |
Thermo Fisher Scientific Inc: Sonstige Angaben (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 17.78 | 16.58 | 15.53 | 17.73 | 19.61 | 16.10 | 9.24 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 7.23 | 6.78 | -12.40 | -9.57 | 21.79 | 74.23 | 26.40 |
| Gewinn je Aktie (verwässert) | 17.74 | 16.54 | 15.45 | 17.64 | 19.46 | 15.98 | 9.17 |
| Veränderung Gewinn je Aktie (verwässert) in % | 7.25 | 7.05 | -12.41 | -9.35 | 21.79 | 74.21 | 26.67 |
| Anzahl Mitarbeiter | - | 125’000 | 122’000 | 130’000 | 130’000 | 80’000 | 75’000 |
| Veränderung Anzahl Mitarbeiter in % | - | 2.46 | -6.15 | 0.00 | 62.50 | 6.67 | 7.14 |
Thermo Fisher Scientific Inc Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Thermo Fisher Scientific Inc | Quartalszahlen | 29.04.2026 |
| Thermo Fisher Scientific Inc | Quartalszahlen | 29.07.2026 |
| Thermo Fisher Scientific Inc | Quartalszahlen | 28.10.2026 |
| Thermo Fisher Scientific Inc | Quartalszahlen | 04.02.2027 |
Thermo Fisher Scientific Inc vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q4 2025 Earnings Release | 29.01.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 22.10.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 23.07.2025 |
| Hauptversammlung | Annual General Meeting | 21.05.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 23.04.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 30.01.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 23.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 24.07.2024 |
| Hauptversammlung | Annual General Meeting | 22.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 24.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 31.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 25.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 26.07.2023 |
| Hauptversammlung | Annual General Meeting | 24.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 26.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 01.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 26.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 28.07.2022 |
| Hauptversammlung | Annual General Meeting | 18.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 28.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 02.02.2022 |
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 75’000 | 80’000 | 130’000 | 130’000 | 122’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.34 | 0.40 | 0.30 | 0.35 | 0.35 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 11’893 | 21’957 | 20’113 | 25’229 | 24’589 |
| Summe Anlagevermögen | 46’488 | 47’095 | 75’010 | 71’925 | 74’137 |
| Summe Aktiva | 58’381 | 69’052 | 95’123 | 97’154 | 98’726 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 28’706 | 34’545 | 54’146 | 53’006 | 51’884 |
| Summe Eigenkapital | 29’675 | 34’507 | 40’977 | 44’148 | 46’842 |
| Summe Passiva | 58’381 | 69’052 | 95’123 | 97’154 | 98’726 |
Adresse
| 168 Third Avenue, 02451 Waltham | |
| Telefon | +1 (781) 622-1000 |
| URL | http://www.thermofisher.com |
Management
|
Aditya Joshi
Chief Strategy Officer & Vice President |
|
Anthony Hugh Smith
Treasurer, Vice President-Tax & Treasury |
|
C. Martin Harris
Independent Director |
|
Daniel P. Shine
Senior VP, President-Analytical Instruments |
|
Daniella Cramp
Senior VP & President-BioProduction Group |
|
Debora L. Spar
Independent Director |
|
Dion J. Weisler
Non-Executive Director |
|
Frederick M. Lowery
President-Laboratory Products & Bioproduction |
|
Gianluca Pettiti
Executive Vice President |
|
James C. Mullen
Independent Director |
|
Jennifer M. Johnson
Independent Director |
|
John Brian Sabo
VP & General Counsel-Customer Channels Group |
|
Joseph R. Holmes
Chief Accounting Officer & Vice President |
|
Julia L. Chen
Secretary & Vice President |
|
Karen E. Nelson
Chief Scientific Officer |
|
Karen S. Lynch
Independent Director |
|
Lisa P. Britt
Chief Human Resources Officer & Senior VP |
|
Marc N. Casper
Chairman, President & Chief Executive Officer |
|
Michel Lagarde
Chief Operating Officer & Executive Vice President |
|
Mike Shafer
Senior VP & President-Pharma Services Group |
|
Nelson J. Chai
Independent Director |
|
R. Alexandra Keith
Independent Director |
|
Rafael Tejada
Vice President-Investor Relations |
|
Ronald Storch
Chief Business Officer & Senior Vice President |
|
Ruby R. Chandy
Independent Director |
|
Ryan Snyder
Chief Information Officer & Senior Vice President |
|
Scott M. Sperling
Lead Independent Director |
|
Sebastian Pacios
Senior Vice President-Clinical Research |
|
Stephen Williamson
Chief Financial Officer & Senior Vice President |
|
Tom B. Shropshire
Senior Vice President & General Counsel |
|
Tyler E. Jacks
Director |